ArticleCancer chemotherapy and pharmacology2025
RNA processing kinase inhibitors and epigenetic inhibitors in combination with oncology drugs or investigational agents in multi-cell type patient-derived tumor cell line spheroids.
Beverly A Teicher et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.